A furious row has broken out between a drugs company and the NHS regulator in England over the price of a new breast cancer treatment.
Kadcyal which is manufactured by Roche Products Limited can give patients with HER2-positive breast cancer an additional six months of life, but the regulator deemed it too expensive.
ITV News correspondent Nina Nannar reports.
More top news
Chuka Umunna has backed Liz Kendall to become the next Labour leader.
At least 13 people were killed in the storm, with searches underway for many more missing.
Children are risking their lives by taking part in a dangerous new social media craze called the paracetamol challenge, police have warned.